Stay updated on NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer
Sign up to get notified when there's something new on the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page.

Latest updates to the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now displays a 403 Forbidden error, making the NEOMUN study record inaccessible. The content including study documents and related details appears to have been removed from the page.SummaryDifference19%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedAdded a funding line: '2016 ( U.S. NIH Grant/Contract )' under Other Study ID Numbers and updated the page revision from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page revision updated from v3.6.4 to v3.6.5, representing a small maintenance update to the ClinicalTrials.gov entry; no substantive study details appear affected.SummaryDifference0.1%

- Check66 days agoChange DetectedA new revision tag v3.6.4 was added to the page, indicating a newer build. The previous revision tag v3.6.3 was removed.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page now shows a new revision entry, Revision: v3.6.3, replacing Revision: v3.6.2, indicating a software version update for the page. This change does not alter study data, eligibility criteria, or results.SummaryDifference0.1%

- Check95 days agoChange DetectedThe page now shows revision v3.6.2 instead of v3.6.0, indicating a small site update to the revision tag. The study details and layout remain unchanged.SummaryDifference0.1%

Stay in the know with updates to NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer
Enter your email address, and we'll notify you when there's something new on the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page.